Thomas Gahm
Technik-/Wissenschafts-/F&E-Leiter bei TriPath Oncology, Inc.
Profil
Thomas Gahm has been Vice President of Research and Development for TriPath Oncology, Inc. since June, 2000.
He was Vice President of Computer Science for TriPath Imaging, Inc. from November, 1996 to May, 2000.
Previously, Dr. Gahm was Vice President of Computer Science for RIAS and RBL.
He was a Scientific Advisor and Project Coordinator of the Image Analysis Division for Kontron Electronics from 1983 to 1993.
Dr. Gahm received a degree in Engineering from the University of Stuttgart (Institute of Physical Electronics) and a PhD from the Medical and Technical University of Hannover, Germany.
Aktive Positionen von Thomas Gahm
Unternehmen | Position | Beginn |
---|---|---|
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Thomas Gahm
Unternehmen | Position | Ende |
---|---|---|
TriPath Imaging, Inc.
TriPath Imaging, Inc. Pharmaceuticals: MajorHealth Technology TriPath Imaging, Inc. engages in the development, manufacture, and market of equipment and products for cervical cytology screening. The company was founded on November 15, 1996 and is headquartered in Burlington, NC. | Corporate Officer/Principal | 30.05.2000 |
Ausbildung von Thomas Gahm
Universität Stuttgart | Undergraduate Degree |
University of Hannover | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Commercial Services |
TriPath Imaging, Inc.
TriPath Imaging, Inc. Pharmaceuticals: MajorHealth Technology TriPath Imaging, Inc. engages in the development, manufacture, and market of equipment and products for cervical cytology screening. The company was founded on November 15, 1996 and is headquartered in Burlington, NC. | Health Technology |